









Markets
/
Stocks
/
nasdaq-xray
/

DENTSPLY SIRONA Inc

XRAY

12.620USD

+0.130+1.04%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

2.52BMarket Cap

LossP/E TTM



DENTSPLY SIRONA Inc

12.620

+0.130+1.04%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of DENTSPLY SIRONA Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DENTSPLY SIRONA Inc's Score

Industry at a Glance

Industry Ranking

68 / 210

Overall Ranking

162 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 16 analysts

Hold

Current Rating

15.792

Target Price

+25.83%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

DENTSPLY SIRONA Inc Highlights

StrengthsRisks

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

Overvalued

The company’s latest PE is -2.67, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 207.47M shares, decreasing 15.21% quarter-over-quarter.

Held by First Eagle Investment

Star Investor First Eagle Investment holds 14.19M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.24.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 6.99, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 936.00M, representing a year-over-year decrease of 4.88%, while its net profit experienced a year-over-year decrease of 1025.00%.

Score

Industry at a Glance

Previous score

6.99

Change



Financials

5.43

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

5.49

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.90

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.57

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.54

Key Metrics

Free cash flow

No Data

DENTSPLY SIRONA Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.76, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -2.67, which is -5.29% below the recent high of -2.53 and -2647.07% above the recent low of -73.45.

Score

Industry at a Glance

Previous score

7.76

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 68/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 6.63, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for DENTSPLY SIRONA Inc is 15.00, with a high of 23.00 and a low of 13.00.

Score

Industry at a Glance

Previous score

6.63

Change

Support & Resistance

No Data

Analyst Rating

Based on 16 analysts

Hold

Current Rating

15.792

Target Price

+26.43%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

DENTSPLY SIRONA Inc

XRAY

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 6.47, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 13.32 and the support level at 11.68, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.41

Change

0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.004

Sell

RSI(14)

41.373

Neutral

STOCH(KDJ)(9,3,3)

26.245

Sell

ATR(14)

0.333

Low Volatility

CCI(14)

-104.137

Sell

Williams %R

75.676

Sell

TRIX(12,20)

-0.024

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

12.620

Sell

MA10

12.856

Sell

MA20

12.675

Sell

MA50

13.142

Sell

MA100

14.187

Sell

MA200

15.161

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 104.00%, representing a quarter-over-quarter increase of 2.18%. The largest institutional shareholder is The Vanguard, holding a total of 21.03M shares, representing 10.54% of shares outstanding, with 4.32% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

21.03M

+1.92%

BlackRock Institutional Trust Company, N.A.

16.83M

-2.05%

First Eagle Investment Management, L.L.C.

Star Investors

14.19M

-1.70%

AQR Capital Management, LLC

13.32M

+109.82%

Fuller & Thaler Asset Management Inc.

12.39M

+2.61%

T. Rowe Price Associates, Inc.

Star Investors

10.76M

-21.88%

Lazard Asset Management, L.L.C.

10.11M

+7.96%

Cooke & Bieler, L.P.

9.15M

-0.03%

State Street Investment Management (US)

7.10M

+5.50%

Dimensional Fund Advisors, L.P.

5.85M

-15.85%

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 6.30, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.